Description     Claims     Drawing  

EP2423208A1   [0008] 

Nature   [0009] 
Remington's Pharmaceutical Sciences   [0073] 
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis   [0124] 
Role of Gas6 in erythropoiesis and anemia in mice   [0124] 
Enveloped Viruses Disable Innate Immune Responses in Dendritic Cells by Direct Activation of TAM Receptors   [0124] 
Oncogenic kinase signalling   [0124] 
S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab   [0124] 
Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases   [0124] 
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival   [0124] 
BR. J. CANCER   [0124] 
The hallmarks od cancer   [0124] 
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily   [0124] 
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases   [0124] 
THYROID   [0124] 
MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation   [0124] 
Immunobiology of the TAM receptors   [0124] 
BLOOD   [0124] 
TAM receptors are pleiotropic inhibitors of the innate immune response   [0124] 
EXP. MCD.   [0124] 
NEOPLASIA   [0124] 
ONCOLOGY   [0124] 
MOL CARCINOG   [0124] 
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer   [0124] 
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma   [0124]